Advertisement
New Zealand markets closed
  • NZX 50

    11,803.28
    -49.52 (-0.42%)
     
  • NZD/USD

    0.5911
    -0.0010 (-0.17%)
     
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • OIL

    81.81
    -0.09 (-0.11%)
     
  • GOLD

    2,313.60
    -32.80 (-1.40%)
     

New Strong Sell Stocks for June 12th

Some investors are rotating out of earlier high flying technology stocks into cheap emerging markets.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

AMN Healthcare Services, Inc. AMN is a provider of healthcare workforce solutions and staffing services. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 60 days.

Ambarella, Inc. AMBA is a developer of semiconductor processing solutions. The Zacks Consensus Estimate for its current year earnings has been revised 45.5% downward over the last 60 days.

BCB Bancorp, Inc. BCBP is a provider of banking products and services. The Zacks Consensus Estimate for its current year earnings has been revised 7.5% downward over the last 60 days.

ADVERTISEMENT

Biohaven Pharmaceutical Holding Company Ltd. BHVN is the owner and operator of a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.7% downward over the last 60 days.

BayCom Corp. BCML is a provider of commercial banking products and services. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AMN Healthcare Services Inc (AMN) : Free Stock Analysis Report
 
Ambarella, Inc. (AMBA) : Free Stock Analysis Report
 
BCB Bancorp, Inc. (NJ) (BCBP) : Free Stock Analysis Report
 
BIOHAVEN PHARM (BHVN) : Free Stock Analysis Report
 
Bay Commercial Bank (BCML) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research